EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES

Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: A. N. Meshkov
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Seri Bilgileri:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Konular:
hypercholesterolemia
ischemic heart disease
atorvastatin
Online Erişim:https://www.rpcardio.com/jour/article/view/820
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller